Jacobs Levy Equity Management Inc. cut its holdings in shares of Diversified Healthcare Trust (NASDAQ:DHC - Free Report) by 74.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 131,773 shares of the real estate investment trust's stock after selling 392,479 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.05% of Diversified Healthcare Trust worth $303,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in DHC. JPMorgan Chase & Co. grew its holdings in Diversified Healthcare Trust by 60.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 863,806 shares of the real estate investment trust's stock valued at $3,619,000 after buying an additional 324,787 shares in the last quarter. SG Americas Securities LLC boosted its stake in Diversified Healthcare Trust by 55.1% in the fourth quarter. SG Americas Securities LLC now owns 116,782 shares of the real estate investment trust's stock valued at $269,000 after buying an additional 41,489 shares in the last quarter. Inspire Investing LLC boosted its stake in Diversified Healthcare Trust by 78.7% in the fourth quarter. Inspire Investing LLC now owns 175,182 shares of the real estate investment trust's stock valued at $403,000 after buying an additional 77,170 shares in the last quarter. ING Groep NV acquired a new stake in shares of Diversified Healthcare Trust during the fourth quarter valued at about $460,000. Finally, Proficio Capital Partners LLC acquired a new stake in shares of Diversified Healthcare Trust during the fourth quarter valued at about $44,000. 75.98% of the stock is owned by institutional investors and hedge funds.
Diversified Healthcare Trust Stock Up 3.0%
Shares of NASDAQ:DHC opened at $3.13 on Monday. The stock has a market cap of $755.12 million, a price-to-earnings ratio of -1.94 and a beta of 2.37. The company has a quick ratio of 11.57, a current ratio of 11.57 and a debt-to-equity ratio of 1.44. Diversified Healthcare Trust has a 12-month low of $2.00 and a 12-month high of $4.24. The business's 50 day moving average is $2.46 and its 200 day moving average is $2.47.
Diversified Healthcare Trust (NASDAQ:DHC - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. Diversified Healthcare Trust had a negative return on equity of 17.55% and a negative net margin of 26.09%. The business had revenue of $386.86 million for the quarter, compared to analysts' expectations of $381.19 million.
Diversified Healthcare Trust Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Tuesday, April 22nd were given a dividend of $0.01 per share. The ex-dividend date was Tuesday, April 22nd. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.28%. Diversified Healthcare Trust's dividend payout ratio is presently -3.28%.
Wall Street Analyst Weigh In
A number of equities analysts have recently issued reports on DHC shares. StockNews.com upgraded Diversified Healthcare Trust from a "sell" rating to a "hold" rating in a research report on Thursday, April 10th. B. Riley began coverage on Diversified Healthcare Trust in a report on Thursday, April 3rd. They issued a "buy" rating and a $4.50 target price for the company.
Get Our Latest Stock Analysis on DHC
About Diversified Healthcare Trust
(
Free Report)
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diversified Healthcare Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diversified Healthcare Trust wasn't on the list.
While Diversified Healthcare Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
